Down-regulation of miR-133a-3p in hepatocellular carcinoma tissues and its potential regulatory molecular mechanism: a study of qRT-PCR and bioinformatics analysis

被引:0
|
作者
Wen, Dong-Yue [1 ]
Xie, Zu-Cheng [2 ]
Luo, Jie [3 ]
Gao, Li [2 ]
Zhang, Xiang-Yu [2 ]
Liang, Hai-Wei [2 ]
Ackbarkhan, Zacharia [4 ]
Wang, Han-Lin [2 ]
Yang, Xia [2 ]
Ye, Zhi-Hua [2 ]
Huang, Xue-Yi [2 ]
He, Yun [1 ]
Yang, Hong [1 ]
Li, Zu-Yun [2 ]
机构
[1] Guangxi Med Univ, Dept Med Ultrason, Affiliated Hosp 1, 6 Shuangyong Rd, Nanning 530021, Guangxi Zhuang, Peoples R China
[2] Guangxi Med Univ, Dept Pathol, Affiliated Hosp 1, Nanning, Guangxi Zhuang, Peoples R China
[3] Guangxi Med Univ, Dept Med Oncol, Affiliated Hosp 1, Nanning, Guangxi Zhuang, Peoples R China
[4] Guangxi Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Nanning, Guangxi Zhuang, Peoples R China
基金
中国国家自然科学基金;
关键词
MiR-133a-3p; hepatocellular carcinoma; RT-qPCR; bioinformatics; target gene; HEPATITIS-B; DECREASED EXPRESSION; TUMOR-SUPPRESSOR; C-SRC; MICRORNA-133A; CANCER; CELLS; PROLIFERATION; GROWTH; MIGRATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs have recently been discovered to be of great importance in regulating biological processes including proliferation differentiation, apoptosis necrosis and invasion. Here, we aimed to verify the clinical implication of miR-133a-3p in hepatocellular carcinoma (HCC) and to explore the underlying regulatory molecular mechanism. Clinical HCC samples (n=95) were enrolled in the present study. The expression of miR-133a-3p was detected by RT-qPCR and its associations with clinicopathological parameters were further analyzed. We next utilized 14 online prediction databases to seek the potential target genes of miR-133a-3p in HCC. The overlapping genes were further evaluated through bioinformatics methods including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), PANTHER and protein-protein interaction network (PPI). We discovered that the expression of miR-133a-3p in HCC was obviously lower than that in non-HCC liver tissues (P<0.001). Besides, the Receiver Operating Characteristic (ROC) curve analysis exhibited the Area Under Curve (AUC) was 0.683. Additionally, the expression of miR-133a-3p also showed statistical correlation with tumor nodes, metastasis, portal vein tumor embolus and vascular invasion (all P<0.05). GO analysis displayed three items, including regulation of cell proliferation, plasma membrane part, protein kinase activity, which were predominant respectively in biological process (BP), cellular component (CC), molecular function (MF). Through PPI, we also achieved 30 hub genes which were the key target genes of miR-133a-3p in HCC. The information we obtained here might offer new perspectives in clinical diagnosis and elucidate part of regulatory molecular mechanism of miR-133-3p in HCC.
引用
收藏
页码:23 / 38
页数:16
相关论文
共 43 条
  • [31] Lower miR-145-5p expression and its potential pathways in hepatocellular carcinoma: a bioinformatics analysis with RNA-seq and microarray data
    Huang, Dongning
    Qin, Li
    Huang, Jian
    Huang, Haixin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04): : 3060 - 3077
  • [32] Protective potential of miR-146a-5p and its underlying molecular mechanism in diverse cancers: a comprehensive meta-analysis and bioinformatics analysis
    Mei-wei Li
    Li Gao
    Yi-wu Dang
    Ping Li
    Zu-yun Li
    Gang Chen
    Dian-zhong Luo
    Cancer Cell International, 19
  • [33] Protective potential of miR-146a-5p and its underlying molecular mechanism in diverse cancers: a comprehensive meta-analysis and bioinformatics analysis
    Li, Mei-wei
    Gao, Li
    Dang, Yi-wu
    Li, Ping
    Li, Zu-yun
    Chen, Gang
    Luo, Dian-zhong
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [34] Down-Regulation of TIMP2 by HIF-1α/miR-210/HIF-3α Regulatory Feedback Circuit Enhances Cancer Metastasis in Hepatocellular Carcinoma
    Kai, Alan Ka-Lun
    Chan, Lo Kong
    Lo, Regina Cheuk-Lam
    Lee, Joyce Man-Fong
    Wong, Carmen Chak-Lui
    Wong, Jack Chun-Ming
    Ng, Irene Oi-Lin
    HEPATOLOGY, 2016, 64 (02) : 473 - 487
  • [35] Expression and Regulatory Network Analysis of MiR-139-3p, a New Potential Serum Biomarker for Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis
    Wang, Yonghong
    Fang, Qimei
    Tian, Liru
    Yuan, Zhongzhen
    Tian, Lizhen
    Zhou, Zhongli
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [36] MiR-331-3p Inhibition of the Hepatocellular Carcinoma (HCC) Bel-7402 Cell Line by Down-Regulation of E2F1
    Jin, Wenjian
    Zhong, Ning
    Wang, Lingling
    Yu, Jieli
    Yin, Fugen
    Zhang, Kunhe
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2019, 19 (09) : 5476 - 5482
  • [37] Down-regulation of BMAL1 by MiR-494-3p Promotes Hepatocellular Carcinoma Growth and Metastasis by Increasing GPAM-mediated Lipid Biosynthesis
    Yang, Yi
    Yang, Tao
    Zhao, Zifeng
    Zhang, Hongxin
    Yuan, Peng
    Wang, Gang
    Zhao, Zheng
    An, Jiaze
    Lyu, Zhuomin
    Xing, Jinliang
    Li, Jibin
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (16): : 6129 - 6144
  • [38] Association of microRNA-23b-3p down-regulation with progression and survival in pancreatic duct adenocarcinoma and its prospective function via bioinformatics analysis
    Liu, Jianghua
    Li, Jianjun
    Chen, Gang
    Cai, Xiaoyong
    Huang, Yubin
    Li, Chunjun
    Gan, Xiaoning
    Wei, Danming
    Dang, Yiwu
    Luo, Dianzhong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (07): : 6645 - 6658
  • [39] Downregulation of miR-199a-3p in Hepatocellular Carcinoma and Its Relevant Molecular Mechanism via GEO, TCGA Database and In Silico Analyses
    Liu, An-gui
    Pang, Yu-yan
    Chen, Gang
    Wu, Hua-Yu
    He, Rong-Quan
    Dang, Yi-wu
    Huang, Zhi-guang
    Zhang, Rui
    Ma, Jie
    Yang, Li-hua
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [40] Comparative study of joint bioinformatics analysis of underlying potential of 'neurimmiR', miR-212-3P/miR-132-3P, being involved in epilepsy and its emerging role in human cancer
    Xia, Lu
    Li, Daojiang
    Lin, Changwei
    Ou, Shuchun
    Li, Xiaorong
    Pan, Songqing
    ONCOTARGET, 2017, 8 (25) : 40668 - 40682